|Bid||17.49 x 2100|
|Ask||17.51 x 100|
|Day's Range||17.22 - 18.01|
|52 Week Range||16.81 - 53.96|
|PE Ratio (TTM)||224.23|
|Dividend & Yield||1.10 (6.44%)|
|1y Target Est||27.00|
NEW YORK, NY / ACCESSWIRE / August 17, 2017 / While it was a good day for one Israeli company, it was a bad day for another. Israeli-based Teva saw its shares fall yesterday after a significant price target ...
If a company makes money by copying the inventions of others, is it entitled to skim a thick layer of cream off the top? That is the question on the lips of investors in generic drugmakers, after a torrid ...
Citigroup cut its rating for the struggling generic drug maker to 'neutral'.